PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: EAP - 65% PAIN REDUCTION IN 10 OA PATIENTS IN USA, page-156

  1. 131 Posts.
    lightbulb Created with Sketch. 19
    10 patients in a subjective assessment of pain reduction? Wake up you guys! If you need more convincing take a look here: "Placebo-controlled clinical trials are the gold standard in drug development, in part to ensure that the efficacy of a new therapy exceeds the placebo response in the indication being studied. In osteoarthritis (OA), placebo treatment can result in pain reduction, functional improvement and stiffness reduction associated of up to 80% of the observed treatment efficacy. In fact, in randomized controlled trials, improvement perceived by OA patients taking placebo can be so great that some experts have suggested administration of placebo as a treatment option"

    https://www.tools4patient.com/the-placebo-response-in-drug-development-part-2-osteoarthritis/
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.